by Jason Heaviland | Jun 2, 2026 | Uncategorized
Transcript featuring Gary Patti (Panome Bio) and Dipender Gill (Sequoia Genetics) DIPENDER So Gary, great to get a chance to talk again. I know we’ve had numerous really stimulating conversations about proteomics, genetics, the intersection of science, and how...
by Jason Heaviland | Apr 30, 2026
Advancing the frontier of translational proteomic insights: Focus on large scale mass spectrometry A fireside conversation for biopharma, investors, and academics about maximizing translational insights from proteomic data by capitalizing on the emergence of...
by Jason Heaviland | Apr 28, 2026 | Uncategorized
What if untargeted metabolomics delivered on its promise? For years, untargeted metabolomics has been one of the most compelling approaches in biology: measure broadly, capture molecular diversity and improve biological interpretation and understanding. In practice,...
by Jason Heaviland | Apr 10, 2026 | Uncategorized
Terms like “comprehensive coverage” and “untargeted detection” are widely used in metabolomics, but they are rarely evaluated in controlled comparisons. Panome Bio conducted a head-to-head study against a widely used legacy platform using identical samples,...
by Jason Heaviland | Mar 31, 2026
Metabolomics Comparison: A Head-to-Head Study Panome Bio conducted a controlled head-to-head metabolomics study using identical samples analyzed by a legacy library-based platform and Next-Generation Metabolomics®️. The results show a nearly 4× increase in detected...
